These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27744012)

  • 1. Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.
    Hinton PS; Nigh P; Thyfault J
    Bone; 2017 Mar; 96():85-90. PubMed ID: 27744012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: A 12-month randomized, clinical trial.
    Hinton PS; Nigh P; Thyfault J
    Bone; 2015 Oct; 79():203-12. PubMed ID: 26092649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.
    Ardawi MS; Rouzi AA; Qari MH
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3691-9. PubMed ID: 22865898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
    Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
    Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sclerostin and parathyroid hormone response to exercise in boys and men.
    Falk B; Haddad F; Klentrou P; Ward W; Kish K; Mezil Y; Radom-Aizik S
    Osteoporos Int; 2016 Mar; 27(3):1245-1249. PubMed ID: 26361948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass.
    Gombos GC; Bajsz V; Pék E; Schmidt B; Sió E; Molics B; Betlehem J
    BMC Musculoskelet Disord; 2016 Jun; 17():254. PubMed ID: 27278385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sclerostin increases in healthy adult men during bed rest.
    Spatz JM; Fields EE; Yu EW; Divieti Pajevic P; Bouxsein ML; Sibonga JD; Zwart SR; Smith SM
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1736-40. PubMed ID: 22767636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin and parathyroid hormone responses to acute whole-body vibration and resistance exercise in young women.
    Sharma-Ghimire P; Chen Z; Sherk V; Bemben M; Bemben D
    J Bone Miner Metab; 2019 Mar; 37(2):358-367. PubMed ID: 29956019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
    Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
    Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls.
    van Lierop AH; Witteveen JE; Hamdy NA; Papapoulos SE
    Eur J Endocrinol; 2010 Nov; 163(5):833-7. PubMed ID: 20817762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin levels and changes in bone metabolism after bariatric surgery.
    Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
    J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.
    Szulc P; Bertholon C; Borel O; Marchand F; Chapurlat R
    J Bone Miner Res; 2013 Apr; 28(4):855-64. PubMed ID: 23165952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study.
    Szulc P; Boutroy S; Vilayphiou N; Schoppet M; Rauner M; Chapurlat R; Hamann C; Hofbauer LC
    J Bone Miner Res; 2013 Aug; 28(8):1760-70. PubMed ID: 23408601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum sclerostin levels and metabolic bone diseases].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2013 Jun; 23(6):877-83. PubMed ID: 23719501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.
    Szulc P; Joly-Pharaboz MO; Marchand F; Delmas PD
    Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.
    Durosier C; van Lierop A; Ferrari S; Chevalley T; Papapoulos S; Rizzoli R
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3873-83. PubMed ID: 23864703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
    Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
    J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
    Gennari L; Merlotti D; Valenti R; Ceccarelli E; Ruvio M; Pietrini MG; Capodarca C; Franci MB; Campagna MS; Calabrò A; Cataldo D; Stolakis K; Dotta F; Nuti R
    J Clin Endocrinol Metab; 2012 May; 97(5):1737-44. PubMed ID: 22399511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.